Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Should Amgen join the biopharma breakup party? Analyst says maybe

23.04.2014 / Fierce Pharma

Now that the Big Pharma breakup craze has moved down the drugmaker food chain to Baxter International, should Big Biotech jump on the trend? Maybe one of that group, an analyst suggests. As <em>Forbes</em> reports, Bernstein analyst Geoffrey Porges figures Amgen offers a decent opportunity for a breakup.

LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: